Drug and Alcohol Dependence
Volume 86, Issue 1 , Pages 55-66 , 5 January 2007

Nullifying drug-induced sensitization: Behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats

  • J. McDaid

      Affiliations

    • Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago Medical Center, 2160 South First Ave., Maywood, IL 60153-5515, United States
    • Present address: Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612, United States.
    • ,
  • C.E. Tedford

      Affiliations

    • Solentix BioSciences, Inc., Poulsbo, WA 98370, United States
    • ,
  • A.R. Mackie

      Affiliations

    • Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago Medical Center, 2160 South First Ave., Maywood, IL 60153-5515, United States
    • ,
  • J.E. Dallimore

      Affiliations

    • Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago Medical Center, 2160 South First Ave., Maywood, IL 60153-5515, United States
    • ,
  • A.L. Mickiewicz

      Affiliations

    • Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago Medical Center, 2160 South First Ave., Maywood, IL 60153-5515, United States
    • ,
  • F. Shen

      Affiliations

    • Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago Medical Center, 2160 South First Ave., Maywood, IL 60153-5515, United States
    • Neuroscience Graduate Program, Loyola University Chicago Medical Center, Maywood, IL 60153, United States
    • ,
  • J.M. Angle

      Affiliations

    • Solentix BioSciences, Inc., Poulsbo, WA 98370, United States
    • ,
  • T.C. Napier

      Affiliations

    • Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago Medical Center, 2160 South First Ave., Maywood, IL 60153-5515, United States
    • Neuroscience Graduate Program, Loyola University Chicago Medical Center, Maywood, IL 60153, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 708 216 8427; fax: +1 708 216 6596.

Received 9 January 2006 ,Revised 28 April 2006 ,Accepted 9 May 2006.

References 

  1. Baumann MH, Rothman RB. Alterations in sertonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans. Soc. Biol. Psychiatry. 1998;44:578–591
  2. Bengtson CP, Lee DJ, Osborne PB. Opposing electrophysiological actions of 5-HT on noncholinergic and cholinergic neurons in the rat ventral pallidum in vitro. J. Neurophysiol. 2004;92:433–443
  3. Besson MJ, Graybiel AM, Nastuk MA. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience. 1988;26:101–119
  4. Bonhomme N, Cador M, Stinus L, Le Moal M, Spampinato U. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study. Brain Res. 1995;675:215–223
  5. Bourdelais A, Kalivas PW. Amphetamine lowers extracellular GABA concentration in the ventral pallidum. Brain Res. 1990;516:132–136
  6. Brady AM, Glick SD, O’Donnell P. Selective disruption of nucleus accumbens gating mechanisms in rats behaviorally sensitized to methamphetamine. J. Neurosci. 2005;25:6687–6695
  7. Callahan PM, Cunningham KA. Modulation of the discriminative stimulus properties of cocaine by 5- HT1B and 5-HT2C receptors. J. Pharmacol. Exp. Ther. 1995;274:1414–1424
  8. Crawford CA, Levine MS. Dopaminergic function in the neostriatum and nucleus accumbens of young and aged Fischer 344 rats. Neurobiol. Aging. 1997;18:57–66
  9. Crawford CA, Choi FY, Kohutek JL, Yoshida ST, McDougall SA. Changes in PKA activity and Gs alpha and Golf alpha levels after amphetamine- and cocaine-induced behavioral sensitization. Synapse. 2004;51:241–248
  10. Cremers TI, Giorgetti M, Bosker FJ, Hogg S, Arnt J, Mork A, et al. Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade. Neuropsychopharmacology. 2004;29:1782–1789
  11. Dave KD, Quinn JL, Harvey JA, Aloyo VJ. Role of central 5-HT2 receptors in mediating head bobs and body shakes in the rabbit. Pharmacol. Biochem. Behav. 2004;77:623–629
  12. Davidson C, Lazarus C, Xiong X, Lee TH, Ellinwood EH. 5-HT(2) receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. Eur. J. Pharmacol. 2002;453:255–263
  13. de Boer TH, Maura G, Raiteri M, de Vos CJ, Wieringa J, Pinder RM. Neurochemical and autonomic pharmacological profiles of the 6-aza- analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology. 1988;27:399–408
  14. de Boer TH, Nefkens F, van Helvoirt A, Van Delft AM. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. J. Pharmacol. Exp. Ther. 1996;277:852–860
  15. Dickinson SL, Curzon G. Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour. Neuropharmacology. 1983;22:805–812
  16. Groenewegen HJ, Russchen FT. Organization of the efferent projections of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a tracing and immunohistochemical study in the cat. J. Comp. Neurol. 1984;223:347–367
  17. Haddjeri N, Blier P, De Montigny C. Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission. J. Affect. Disord. 1998;51:255–266
  18. Hamamura T, Akiyama K, Akimoto K, Kashihara K, Okumura K, Ujike H, et al. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 1991;546:40–46
  19. He C, Voigt RM, Dallimore JE, McDaid J, Chefer VI, Shippenberg TS, et al. Cocaine-induced behavioral sensitization: correlation with attenuated dopamine release in the ventral pallidum. Soc. Neurosci. Abstr. 2004;30(688.8):
  20. Heidbreder CA, Oertle T, Feldon J. Dopamine and serotonin imbalances in the left anterior cingulate and pyriform cortices following the repeated intermittent administration of cocaine. Neuroscience. 1999;89:701–715
  21. Heidenreich BA, Napier TC. Effects of serotonergic 5-HT1A and 5-HT1B ligands on ventral pallidal neuronal activity. Neuroreport. 2000;11:2849–2853
  22. Heidenreich BA, Mailman RB, Nichols DE, Napier TC. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine. J. Pharmacol. Exp. Ther. 1995;273:516–525
  23. Henry DJ, White FJ. Electrophysiological correlates of psychomotor stimulant-induced sensitization. Ann. N.Y. Acad. Sci. 1992;654:88–100
  24. Henry DJ, White FJ. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J. Neurosci. 1995;15:6287–6299
  25. Hensler JG, Truett KA. Effect of chronic serotonin-2 receptor agonist or antagonist administration on serotonin-1A receptor sensitivity. Neuropsychopharmacology. 1998;19:354–364
  26. Hess EJ, Norman AB, Creese I. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors. J. Neurosci. 1988;8:2361–2370
  27. Hoyer D. Functional correlates of serotonin 5-HT1 recognition sites. J. Recept. Res. 1988;8:59–71
  28. Hummel M, Unterwald EM. D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action. J. Cell Physiol. 2002;191:17–27
  29. Istre ED, Napier TC, Wolf WA. Enhanced sensitivity to ventral pallidal serotonin receptors activation after withdrawal from repeated mehtamphetamine treatment. Soc. Neurosci. Abstr. 2002;27(878.11):27
  30. Jones BE, Cuello AC. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic – catecholamine, serotonin, and acetylcholine – neurons. Neuroscience. 1989;31:37–61
  31. Jones DL, Mogenson GJ. Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity. Am. J. Physiol. 1980;238:R65–R69
  32. Kalivas PW, Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 1993;13:266–275
  33. Kelder J, Funke C, De Boer T, Delbressine L, Leysen D, Nickolson V. A comparison of the physicochemical and biological properties of mirtazapine and mianserin. J. Pharm. Pharmacol. 1997;49:403–411
  34. Kongsakon R, Papadopoulos KI, Saguansiritham R. Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study. Int. Clin. Psychopharmacol. 2005;20:253–256
  35. Kooyman AR, Zwart R, Vanderheijden PM, Van Hooft JA, Vijverberg HP. Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells. Neuropharmacology. 1994;33:501–507
  36. Kuribara H, Uchihashi Y. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice. J. Pharm. Pharmacol. 1993;45:1042–1045
  37. Li Y, White FJ, Wolf ME. Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacology. 2000;151:175–183
  38. Ling W, Shoptaw S. Integration of research in pharmacotherapy for addictive disease: where are we? Where are we going?. J. Addict. Dis. 1997;16:83–102
  39. Maslowski RJ, Napier TC. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons. Eur. J. Pharmacol. 1991;200:103–112
  40. McDaid J, Dallimore JE, Mackie AR, Mickiewicz AL, Napier TC. Cross-sensitization to morphine in cocaine-sensitized rats: behavioral assessments correlate with enhanced responding of ventral pallidal neurons to morphine and glutamate, with diminished effects of GABA. J. Pharmacol. Exp. Ther. 2005;313:1182–1193
  41. McGrath C, Burrows GD, Norman TR. Neurochemical effects of the enantiomers of mirtazapine in normal rats. Eur. J. Pharmacol. 1998;356:121–126
  42. McMahon LR, Filip M, Cunningham KA. Differential regulation of the mesoaccumbens circuit by serotonin 5- hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J. Neurosci. 2001;21:7781–7787
  43. Mengual E, Pickel VM. Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum. Synapse. 2002;43:151–162
  44. Meredith GE, Switzer RC, Napier TC. Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum. Brain Res. 2004;995:14–22
  45. Mitrovic I, Napier TC. Interactions between the mu opioid agonist DAMGO and substance P in regulation of the ventral pallidum. Synapse. 1996;23:142–151
  46. Munzar P, Laufert MD, Kutkat SW, Novakova J, Goldberg SR. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J. Pharmacol. Exp. Ther. 1999;291:239–250
  47. Napier TC, Maslowski RJ. Electrophysiological verification for the presence of D1 and D2 dopamine receptors within the ventral pallidum. Synapse. 1994;17:160–166
  48. Napier TC, Potter PE. Dopamine in the rat ventral pallidum/substantia innominata: biochemical and electrophysiological studies. Neuropharmacology. 1989;28:757–760
  49. Napier TC, Muench MB, Maslowski RJ, Battaglia G. Is dopamine a neurotransmitter within the ventral pallidum/substantia innominata. Adv. Exp. Med. Biol. 1991;295:183–195
  50. Parsons LH, Justice JB. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 1993;61:1611–1619
  51. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press; 1998;
  52. Pazos A, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 1985;346:205–230
  53. Pazos A, Cortes R, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 1985;346:231–249
  54. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 1993;18:247–291
  55. Robinson TE, Jurson PA, Bennett JA, Bentgen KM. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 1988;462:211–222
  56. Rothman RB, Baumann MH. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 2003;479:23–40
  57. Schama KF, Howell LL, Byrd LD. Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys. Psychopharmacology (Berl.). 1997;132:27–34
  58. Self DW, Nestler EJ. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 1995;18:463–495
  59. Semba K, Reiner PB, McGeer EG, Fibiger HC. Brainstem afferents to the magnocellular basal forebrain studied by axonal transport, immunohistochemistry, and electrophysiology in the rat. J. Comp. Neurol. 1988;267:433–453
  60. Shimada A, Yamaguchi K, Yanagita T. Neurochemical analysis of the psychotoxicity of methamphetamine and cocaine by microdialysis in the rat brain. Ann. N.Y. Acad. Sci. 1996;801:361–370
  61. Shishido T, Watanabe Y, Suzuki H, Kato K, Niwa S, Hanoune J, et al. Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum. Neurosci. Lett. 1997;222:175–178
  62. Shuto T, Kuroiwa M, Hamamura M, Yabuuchi K, Shimazoe T, Watanabe S, et al. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D(1) receptor agonist. Neuropharmacology. 2006;50:991–997
  63. Sizemore GM, Co C, Smith JE. Ventral pallidal extracellular fluid levels of dopamine, serotonin, gamma amino butyric acid, and glutamate during cocaine self-administration in rats. Psychopharmacology (Berl.). 2000;150:391–398
  64. Smith JE, Koves TR, Co C. Brain neurotransmitter turnover rates during rat intravenous cocaine self-administration. Neuroscience. 2003;117:461–475
  65. Sprouse JS, Aghajanian GK. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse. 1987;1:3–9
  66. Steketee JD. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants.. Brain Res. Brain Res. Rev. 2003;41:203–228
  67. Stewart J, Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 1993;4:289–312
  68. Subramaniam S, Lucki I, McGonigle P. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Brain Res. 1992;571:313–322
  69. Tran-Nguyen LT, Baker DA, Grote KA, Solano J, Neisewander JL. Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology (Berl.). 1999;146:60–66
  70. Turner MS, Lavin A, Grace AA, Napier TC. Regulation of limbic information outflow by the subthalamic nucleus: excitatory amino acid projections to the ventral pallidum. J. Neurosci. 2001;21:2820–2832
  71. Turner MS, Mignon L, Napier TC. Alterations in responses of ventral pallidal neurons to excitatory amino acids after long-term dopamine depletion. J. Pharmacol. Exp. Ther. 2002;301:371–381
  72. Ujike H, Akiyama K, Otsuki S. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology (Berl.). 1990;102:459–464
  73. van Wijngaarden I, Tulp MT, Soudijn W. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 1990;188:301–312
  74. White FJ, Kalivas PW. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 1998;51:141–153
  75. White FJ, Wang RY. Electrophysiological evidence for the existence of Both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. J. Neurosci. 1986;6:274–280
  76. Wise RA. D1- and D2-type contributions to psychomotor sensitization and reward: Implications for pharmacological treatment strategies. Clin. Neuropharmacol. 1995;18(Suppl. 1):S74–S83
  77. Yang CR, Mogenson GJ. Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens. Brain Res. 1989;489:237–246
  78. Zhang J, Walsh RR, Xu M. Probing the role of the dopamine D1 receptor in psychostimulant addiction. Ann. N.Y. Acad. Sci. 2000;914:13–21
  79. Zilles K, Werner L, Qü M, Schleicher A, Gross G. Quantitative autoradiography of 11 different transmitter binding sites in the basal forebrain region of the rat—evidence of heterogeneity in distribution patterns. Neuroscience. 1991;42:473–481

PII: S0376-8716(06)00179-7

doi: 10.1016/j.drugalcdep.2006.05.014

Drug and Alcohol Dependence
Volume 86, Issue 1 , Pages 55-66 , 5 January 2007

Article Tools

* Image Usage & Resolution